FCM
MRTX

Frontier Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Frontier Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-43,020
Closed -$3.15M – 306
2019
Q1 		$3.15M Buy
+43,020
New +$3.15M 0.02% 276